Vasamed, Inc.
VSMD · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $1 |
| % Growth | 10.7% | 1.5% | -20.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30.4% | 11.3% | 12.2% | 18.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 240.7% | 267% | 259.6% | 169.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$1 | -$1 |
| % Margin | -334.5% | -362.5% | -270.7% | -170.6% |
| EPS | -0.45 | -0.44 | -0.32 | -0.26 |
| % Growth | -2.3% | -37.5% | -23.1% | – |
| EPS Diluted | -0.45 | -0.44 | -0.32 | -0.26 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 4 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -155% | -177% | -247.2% | -161.9% |